Tradestie Institutional Equity Comparison Engine

AVNS vs DCTH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DCTH Overall Edge

DCTH Captures Institutional Edge (3โ€“1 Pillars ยท 3โ€“7 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while AVNS counters with relative strength in Valuation. Fundamentally, AVNS trades at 20.0x Forward P/E with 5.4% operating margin (+8.8% YoY revenue) versus DCTH at N/M Forward P/E and 5.2% operating margin (+70.7% YoY). In options structure, AVNS sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AVNS
AVNS 20.0x vs DCTH N/M Fwd P/E
Growth & Margin Winner DCTH
Op Margin 5.4% vs 5.2% ยท YoY +8.8% vs +70.7%
Momentum & Technical Winner DCTH
1Y +106.4% vs +128.6% ยท 52W Pos 97% vs 80%
Options & Structure Winner DCTH
UNCLASSIFIED (50th %ile IV) vs BREAKOUT (43rd %ile IV)
AVNS NYSE
Avanos Medical, Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$24.99
+0.04% 1D
Market Cap $1.2B
1M Return +0.16%
1Y Return +106.36%
Forward P/E 20.0x
Unified AI Score
56.7 / 100 HOLD
Tech 75.0 Fund 59.0 Flow 50.0 Mom 46.9
DCTH NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap $743.8M
1M Return +39.77%
1Y Return +128.57%
Forward P/E N/M
Unified AI Score
35.9 / 100 SELL
Tech 50.0 Fund 38.0 Flow 60.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AVNS +106.36% DCTH +128.57% Spread: +70.75 pp (AVNS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AVNS TTM Op. Margin: 5.4% DCTH TTM Op. Margin: 5.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AVNS vs DCTH. Trailing 12-month operating profitability (AVNS 5.4% vs DCTH 5.2%) and valuation multiples (AVNS 20.0x vs DCTH N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AVNS (7) vs DCTH (3)
Institutional Metric AVNS DCTH Criterion Row Winner
Market Capitalization Scale $1.2B $743.8M Larger Scale AVNS
Trailing P/E Ratio Valuation 30.7x 133.6x Lower Multiple AVNS
Forward P/E Ratio Valuation 20.0x N/M Lower Multiple AVNS
Revenue Growth (YoY) Growth +8.8% +70.7% Higher Growth DCTH
Operating Margin (TTM) Profitability 5.4% 5.2% Higher Margin AVNS
Net Profit Margin Profitability -10.4% 6.0% Higher Margin DCTH
Return on Equity (ROE) Capital Efficiency -9.2% 5.4% Higher ROE DCTH
52-Week Range Position Momentum 97% ($9โ€“$25) 80% ($8โ€“$23) Stronger Trend AVNS
Beta / 30D Volatility Risk Regime 1.22ฮฒ ยท 6% Vol 1.63ฮฒ ยท 131% Vol Lower Realized Risk AVNS
Unified Institutional Score Composite Signal 56.7 / 100 (HOLD) 35.9 / 100 (SELL) Higher Composite AVNS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AVNS vs DCTH Buy Guide
AVNS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live AVNS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DCTH BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live DCTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AVNS nor DCTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.